 |
PDBsum entry 2fo5
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
2fo5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of recombinant barley cysteine endoprotease b isoform 2 (ep-b2) in complex with leupeptin
|
|
Structure:
|
 |
Cysteine proteinase ep-b 2. Chain: a, b, c, d. Fragment: cystein proteinase ep-b2 domain, residues 133-356. Engineered: yes. Ace-leu-leu-argininal (leupeptin). Chain: e, f, g, h. Engineered: yes
|
|
Source:
|
 |
Hordeum vulgare. Organism_taxid: 4513. Gene: epb2. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Synthetic: yes. Actinomycetes streptomyces roseus ma 839-a1. Organism_taxid: 66430. Other_details: chemically synthesized
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
2.20Å
|
R-factor:
|
0.201
|
R-free:
|
0.233
|
|
|
Authors:
|
 |
M.T.Bethune,P.Strop,A.T.Brunger,C.Khosla
|
Key ref:
|
 |
M.T.Bethune
et al.
(2006).
Heterologous expression, purification, refolding, and structural-functional characterization of EP-B2, a self-activating barley cysteine endoprotease.
Chem Biol,
13,
637-647.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
12-Jan-06
|
Release date:
|
18-Jul-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P25250
(CYSP2_HORVU) -
Cysteine proteinase EP-B 2 from Hordeum vulgare
|
|
|
|
Seq: Struc:
|
 |
 |
 |
373 a.a.
224 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Chem Biol
13:637-647
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Heterologous expression, purification, refolding, and structural-functional characterization of EP-B2, a self-activating barley cysteine endoprotease.
|
|
M.T.Bethune,
P.Strop,
Y.Tang,
L.M.Sollid,
C.Khosla.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We describe the heterologous expression in Escherichia coli of the proenzyme
precursor to EP-B2, a cysteine endoprotease from germinating barley seeds. High
yields (50 mg/l) of recombinant proEP-B2 were obtained from E. coli inclusion
bodies in shake flask cultures following purification and refolding. The zymogen
was rapidly autoactivated to its mature form under acidic conditions at a rate
independent of proEP-B2 concentration, suggesting a cis mechanism of
autoactivation. Mature EP-B2 was stable and active over a wide pH range and
efficiently hydrolyzed a recombinant wheat gluten protein, alpha2-gliadin, at
sequences with known immunotoxicity in celiac sprue patients. The X-ray crystal
structure of mature EP-B2 bound to leupeptin was solved to 2.2 A resolution and
provided atomic insights into the observed subsite specificity of the
endoprotease. Our findings suggest that orally administered proEP-B2 may be
especially well suited for treatment of celiac sprue.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Crystal Structure of Mature EP-B2 Complexed with
Leupeptin
|
 |
Figure 6.
Figure 6. Activity of EP-B2 against the Proteolytically
Resistant 33-mer Peptide from α2-Gliadin
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Chem Biol
(2006,
13,
637-647)
copyright 2006.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Pinier,
G.Fuhrmann,
E.Verdu,
and
J.C.Leroux
(2010).
Prevention measures and exploratory pharmacological treatments of celiac disease.
|
| |
Am J Gastroenterol,
105,
2551.
|
 |
|
|
|
|
 |
J.Ehren,
B.Morón,
E.Martin,
M.T.Bethune,
G.M.Gray,
and
C.Khosla
(2009).
A food-grade enzyme preparation with modest gluten detoxification properties.
|
| |
PLoS One,
4,
e6313.
|
 |
|
|
|
|
 |
M.T.Bethune,
M.Siegel,
S.Howles-Banerji,
and
C.Khosla
(2009).
Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.
|
| |
J Pharmacol Exp Ther,
329,
657-668.
|
 |
|
|
|
|
 |
B.Morón,
M.T.Bethune,
I.Comino,
H.Manyani,
M.Ferragud,
M.C.López,
A.Cebolla,
C.Khosla,
and
C.Sousa
(2008).
Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide.
|
| |
PLoS ONE,
3,
e2294.
|
 |
|
|
|
|
 |
M.T.Bethune,
and
C.Khosla
(2008).
Parallels between pathogens and gluten peptides in celiac sprue.
|
| |
PLoS Pathog,
4,
e34.
|
 |
|
|
|
|
 |
M.T.Bethune,
E.Ribka,
C.Khosla,
and
K.Sestak
(2008).
Transepithelial transport and enzymatic detoxification of gluten in gluten-sensitive rhesus macaques.
|
| |
PLoS ONE,
3,
e1857.
|
 |
|
|
|
|
 |
R.Ghosh,
S.Chakraborty,
C.Chakrabarti,
J.K.Dattagupta,
and
S.Biswas
(2008).
Structural insights into the substrate specificity and activity of ervatamins, the papain-like cysteine proteases from a tropical plant, Ervatamia coronaria.
|
| |
FEBS J,
275,
421-434.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Vora,
J.McIntire,
P.Kumar,
M.Deshpande,
and
C.Khosla
(2007).
A scaleable manufacturing process for pro-EP-B2, a cysteine protease from barley indicated for celiac sprue.
|
| |
Biotechnol Bioeng,
98,
177-185.
|
 |
|
|
|
|
 |
J.Gass,
H.Vora,
A.F.Hofmann,
G.M.Gray,
and
C.Khosla
(2007).
Enhancement of dietary protein digestion by conjugated bile acids.
|
| |
Gastroenterology,
133,
16-23.
|
 |
|
|
|
|
 |
J.Gass,
M.T.Bethune,
M.Siegel,
A.Spencer,
and
C.Khosla
(2007).
Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue.
|
| |
Gastroenterology,
133,
472-480.
|
 |
|
|
|
|
 |
N.Cerf-Bensussan,
T.Matysiak-Budnik,
C.Cellier,
and
M.Heyman
(2007).
Oral proteases: a new approach to managing coeliac disease.
|
| |
Gut,
56,
157-160.
|
 |
|
|
|
|
 |
D.Stepniak,
and
F.Koning
(2006).
Enzymatic gluten detoxification: the proof of the pudding is in the eating!
|
| |
Trends Biotechnol,
24,
433-434.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |